INTERPACE BIOSCIENCES, INC.
IDXGUS売上高
$39M
百万USD
営業利益
$4M
百万USD
純利益
$25M
百万USD
ROE
109.9%
最新FY
EPS
$0.89
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $10M | $-4M | - |
| FY2021 | Q2 | $11M | $-3M | - |
| FY2021 | Q3 | $9M | $-4M | - |
| FY2021 | FY | $41M | $-15M | - |
| FY2022 | Q1 | $10M | $-2M | - |
| FY2022 | Q2 | $9M | $-4M | - |
| FY2022 | Q3 | $8M | $-14M | - |
| FY2022 | FY | $32M | $-22M | - |
| FY2023 | Q1 | $10M | $0M | $0.08 |
| FY2023 | Q2 | $11M | $0M | $0.04 |
| FY2023 | Q3 | $9M | $-1M | $-0.14 |
| FY2023 | FY | $40M | $1M | $0.18 |
| FY2024 | Q1 | $10M | $0M | $0.11 |
| FY2024 | Q2 | $12M | $2M | $0.47 |
| FY2024 | Q3 | $12M | $1M | $0.29 |
| FY2024 | FY | $47M | $7M | $0.40 |
| FY2025 | Q1 | $12M | $2M | $0.06 |
| FY2025 | Q2 | $9M | $-1M | $-0.14 |
| FY2025 | Q3 | $9M | $1M | $0.03 |
| FY2025 | FY | $39M | $25M | $0.89 |
| FY2026 | Q1 | $9M | $1M | $0.03 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $22M | $24M | $32M | $41M | $32M | $40M | $47M | $39M |
| 営業利益 | $-6M | $-6M | $-12M | $-26M | $-26M | $-14M | $-4M | $3M | $8M | $4M |
| 純利益 | $-8M | $-12M | $-12M | $-27M | $-26M | $-15M | $-22M | $1M | $7M | $25M |
| 総資産 | $42M | $54M | $48M | $52M | $46M | $38M | $16M | $13M | $15M | $34M |
| 純資産 | $7M | - | - | - | - | - | - | - | - | - |
| 自己資本 | $7M | $40M | $33M | $-4M | $-29M | $-42M | $-63M | $-62M | $-2M | $22M |
| 営業CF | $-9M | $-15M | $-9M | $-19M | $-14M | $-9M | $-8M | $4M | $5M | $6M |
| EPS | - | - | - | - | - | - | - | $0.18 | $0.40 | $0.89 |
| BPS | $0.97 | $1.43 | $0.86 | $-1.11 | $-7.07 | $-10.04 | $-14.63 | $-14.09 | $-0.50 | $0.81 |
| ROE | -127.6% | -30.6% | -37.0% | 597.0% | 91.0% | 35.2% | 34.8% | -1.3% | -302.3% | 109.9% |